International twinning partnerships: An effective method of improving diagnosis, treatment and care for children with cancer in low-middle income countries

[1]  S. Howard,et al.  SIOP PODC: Recommendations for supportive care of children with cancer in a low‐income setting , 2013, Pediatric blood & cancer.

[2]  F. Doz,et al.  SIOP‐PODC recommendations for graduated‐intensity treatment of retinoblastoma in developing countries , 2013, Pediatric blood & cancer.

[3]  R. Barr,et al.  Pediatr Blood Cancer 2013 ; 60 : 889 – 891 Essential Medicines for Pediatric Oncology in Developing Countries , 2013 .

[4]  Igor Rudan,et al.  Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? , 2013, The Lancet.

[5]  J. Orem,et al.  The management of children with Kaposi sarcoma in resource limited settings , 2013, Pediatric blood & cancer.

[6]  E. Steliarova-Foucher,et al.  Paediatric cancer in low-income and middle-income countries. , 2013, The Lancet. Oncology.

[7]  P. Hesseling,et al.  Practical recommendations for the management of children with Endemic Burkitt Lymphoma (BL) in a resource limited setting , 2013, Pediatric blood & cancer.

[8]  K. Pritchard-Jones,et al.  Children with cancer: driving the global agenda. , 2013, The Lancet. Oncology.

[9]  Rob Pieters,et al.  Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries. , 2013, The Lancet. Oncology.

[10]  K. Pritchard-Jones,et al.  SIOP PODC: Clinical guidelines for the management of children with Wilms tumour in a low income setting , 2013, Pediatric blood & cancer.

[11]  G. Chagaluka,et al.  Management of Children With a Wilms Tumor in Malawi, Sub-Saharan Africa , 2012, Journal of pediatric hematology/oncology.

[12]  Jamie Perin,et al.  Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000 , 2012, The Lancet.

[13]  S. Barsaoui,et al.  Treatment of nephroblastoma in Africa: Results of the first French African pediatric oncology group (GFAOP) study , 2012, Pediatric blood & cancer.

[14]  J. Cleary,et al.  Ensuring Patient Access to Essential Medicines While Minimizing Harmful Use: A Revised World Health Organization Tool to Improve National Drug Control Policy , 2011, Journal of pain & palliative care pharmacotherapy.

[15]  S. Gupta,et al.  Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. , 2011, The Lancet. Oncology.

[16]  J. Poole,et al.  The Saint Siluan warning signs of cancer in children: Impact of education in rural South Africa , 2011, Pediatric blood & cancer.

[17]  S. Day,et al.  Development of the Latin American Center for pediatric oncology nursing education , 2011, Pediatric blood & cancer.

[18]  D. Stefan,et al.  Delay and causes of delay in the diagnosis of childhood cancer in Africa , 2011, Pediatric blood & cancer.

[19]  Kenneth Hill,et al.  Levels and trends in child mortality, 1990–2009 , 2010, The Lancet.

[20]  C. Rodríguez-Galindo,et al.  Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators , 2010, British Journal of Ophthalmology.

[21]  R. Ribeiro,et al.  Strategies to improve care for children with cancer in Sub-Saharan Africa. , 2010, European journal of cancer.

[22]  Gareth Jones,et al.  Levels and trends in under-5 mortality, 1990–2008 , 2010, The Lancet.

[23]  K. Ribeiro,et al.  Familial retinoblastoma in developing countries , 2009, Pediatric blood & cancer.

[24]  S. Hunger,et al.  Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low‐income countries: A proposal , 2009, Pediatric blood & cancer.

[25]  R. Broadhead,et al.  Endemic Burkitt lymphoma: a 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate , 2009, Annals of tropical paediatrics.

[26]  D Ross-Degnan,et al.  Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis , 2009, The Lancet.

[27]  A. Moll,et al.  The Effect of Therapy Refusal Against Medical Advice in Retinoblastoma Patients in a Setting Where Treatment Delays are Common , 2009, Ophthalmic genetics.

[28]  H. Caron,et al.  The guardians' perspective on paediatric cancer treatment in Malawi and factors affecting adherence , 2008, Pediatric blood & cancer.

[29]  S. Howard,et al.  Global child health priorities: what role for paediatric oncologists? , 2008, European journal of cancer.

[30]  H. Caron,et al.  Nutritional status at admission of children with cancer in Malawi , 2008, Pediatric blood & cancer.

[31]  Eva Steliarova-Foucher,et al.  Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. , 2008, The Lancet. Oncology.

[32]  A. Jack.  Europe’s drug companies are better than those in US in making drugs accessible to poor countries , 2008, BMJ : British Medical Journal.

[33]  T. Eden,et al.  The problem of treatment abandonment in children from developing countries with cancer , 2007, Pediatric blood & cancer.

[34]  L. McGregor,et al.  Pediatric cancers in the new millennium: dramatic progress, new challenges. , 2007, Oncology.

[35]  C. Pui,et al.  Improving outcomes for children with cancer in low‐income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)‐Part I , 2007, Pediatric blood & cancer.

[36]  Z. E. Haffaf,et al.  Traitement des cancers de l'enfant en Afrique : résultats préliminaires du groupe francoafricain d'oncologie pédiatrique , 2005 .

[37]  C. Pui,et al.  Saving the children--improving childhood cancer treatment in developing countries. , 2005, The New England journal of medicine.

[38]  R. Ribeiro,et al.  A formulary for pediatric oncology in developing countries , 2005, Pediatric blood & cancer.

[39]  S. Howard,et al.  Delays in diagnosis and treatment of childhood cancer: Where in the world are they important? , 2005, Pediatric blood & cancer.

[40]  D. Campana,et al.  Development of a regional flow cytometry center for diagnosis of childhood leukemia in Central America , 2005, Leukemia.

[41]  H. Gattamaneni,et al.  Symptom interval in young people with bone cancer. , 2004, European journal of cancer.

[42]  C. Pui,et al.  Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. , 2004, JAMA.

[43]  C. Pui,et al.  Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop , 2004, Leukemia.

[44]  C. Pui,et al.  Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries , 2003, The Lancet.

[45]  R. Ribeiro,et al.  Training subspecialty nurses in developing countries: methods, outcome, and cost. , 2003, Medical and pediatric oncology.

[46]  T. Eden.  Translation of cure for acute lymphoblastic leukaemia to all children. , 2002, British journal of haematology.

[47]  K. Sikora,et al.  Essential drugs for cancer therapy: a World Health Organization consultation. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[48]  F. Cavalli,et al.  North-South twinning in paediatric haemato-oncology: the La Mascota programme, Nicaragua , 1998, The Lancet.

[49]  S. Love,et al.  Determinants of symptom interval in childhood cancer. , 1993, Archives of disease in childhood.

[50]  I. Magrath,et al.  Long‐term experience with burkitt's lymphoma in uganda , 1980, International journal of cancer.

[51]  W. Waldhäusl,et al.  ANTIDEPRESSANT DRUGS AND THE HYPOTHALAMIC-PITUITARY-THYROID AXIS , 1980, The Lancet.

[52]  C. Patte,et al.  [Treatment of childhood cancer in Africa. Preliminary results of the French-African paediatric oncology group]. , 2005, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[53]  Z. Bánkowski,et al.  Health technology transfer, whose responsibility? : XXIIIrd CIOMS Round Table Conference, Geneva, Switzerland, 2-3 November 1989 , 1990 .